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Edited by Stuart FergusonAbstract The mechanism-based inhibitor 2,4-dinitrophenyl 2-
deoxy-2-ﬂuoro-b-D-galactopyranoside (DNP2FGal) was used
to inactivate the Family 42 b-galactosidase (YesZ) from Bacillus
subtilis via the trapping of a glycosyl-enzyme intermediate,
thereby tagging the catalytic nucleophile in the active site.
Proteolytic digestion of the inactivated enzyme and of a control
sample of unlabeled enzyme, followed by comparative high-
performance liquid chromatography and mass spectrometric
analysis identiﬁed a labelled peptide of the sequence ETS-
PSYAASL. These data, combined with sequence alignments of
this region with representative members of Family 42, unequivo-
cally identify the catalytic nucleophile in this enzyme as Glu-295,
thereby providing the ﬁrst direct experimental proof of the iden-
tity of this residue within Family 42.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Glycosidases play crucial roles in biology, and increasingly
in biotechnology, through the cleavage of glycosidic bonds un-
der mild conditions. A very large number of such enzymes are
now known, consistent with the many diﬀerent naturally
occurring glycosidic linkages that must be cleaved, and these
enzymes have been classiﬁed into families on the basis of ami-
no acid sequence similarities [1–3]. Amongst the more biotech-
nologically interesting glycosidases are the b-galactosidases,
which have found particular application in the generation of
lactose-free products [4,5]. b-Galactosidases are found in four
principal carbohydrate-active enzymes (CAZY) families to
date, GH1, GH2, GH35 and GH42, all of which belong to
Clan GH-A. Enzymes in this clan, thus in all four of these
families, are believed to use a two-step, double-displacementAbbreviations: DNP, 2,4-dinitrophenol; PNP, para-nitrophenol;
DNP2FGal, 2,4-dinitrophenyl 2-deoxy-2-ﬂuoro-b-D-galactopyrano-
side; ESI, electrospray ionization; GH, glycosyl hydrolase; HPLC,
high-performance liquid chromatography; MS, mass spectrometry;
CAZY, carbohydrate-active enzymes
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doi:10.1016/j.febslet.2007.04.053mechanism in which a covalent glycosyl-enzyme intermediate
is formed and hydrolyzed via oxocarbenium ion-like transition
states [6,7]. This is eﬀected in an active site containing two key
carboxylic acid residues approximately 5.5 A˚ apart; the cata-
lytic nucleophile, which attacks the sugar anomeric centre
and becomes covalently attached to the galactosyl moiety
and the acid/base residue which protonates the departing agly-
cone oxygen in the ﬁrst step and deprotonates the attacking
water molecule in the second step [8]. The identiﬁcation of
these key carboxylic acids is the ﬁrst step in the mechanistic
characterization of a retaining glycosidase family. While these
residues have been experimentally deﬁned for the b-galactosid-
ases from Families 1, 2 and 35 [9–11], they are only inferred for
the Family 42 enzymes on the basis of the proposed member-
ship of this Family in Clan GH-A [12], and from the three-
dimensional structure of a complex of one of these enzymes
(the b-galactosidase from Thermus thermophilus) with the
product galactose [13]. Experimental veriﬁcation was therefore
required.
The reagents of choice for the tagging and identiﬁcation of
the catalytic nucleophile are the 2-deoxy-2-ﬂuoroglycosides
bearing good leaving groups [14,15]. The ﬂuorine at C2 serves
to destabilize the oxocarbenium ion-like transition states,
thereby slowing both the glycosylation and deglycosylation
steps, while the presence of a good leaving group (typically
ﬂuoride or dinitrophenolate) ensures that the intermediate is
kinetically accessible [16]. As a consequence the intermediate
accumulates. Comparative peptide mapping of proteolytic di-
gests allows the identiﬁcation of the labelled peptide, whence
sequencing locates the catalytic nucleophile [17].
This manuscript describes the cloning and expression of a
representative Family 42 glycosidase, the b-galactosidase
(YesZ) from Bacillus subtilis. It further describes the kinetic
characterization of the mechanism-based inactivation of the
wild type and putative acid/base mutant of this enzyme
by 2,4-dinitrophenyl 2-deoxy-2-ﬂuoro-b-D-galactopyranoside
(DNP2FGal) and the identiﬁcation of the amino acid residue
labelled in this manner by comparative high-performance li-
quid chromatography–mass spectrometry (HPLC–MS) pep-
tide mapping and tandem MS sequencing.
2. Materials and methods
2.1. General
2,4-Dinitrophenyl 2-deoxy-2-ﬂuoro-b-D-galactopyranoside (DNP2-
FGal) was synthesized as previously published [18]. Pepsin (from
porcine mucosa) was purchased from Roche. All other chemicals
and reagents were purchased from Sigma unless otherwise noted.blished by Elsevier B.V. All rights reserved.
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The gene coding for YesZ was ampliﬁed by PCR from genomic B.
subtilis DNA (ATCC Number: 23857D-5) using primers Bsu_yes_fw
(C ACC ATG AGA AAA CTG TAT CAT GGC GCT TG) and
Bsu_yes_rv (GAG ATT GTC AAA TTG AAT CAC ACG GTA
TTC). Pwo polymerase was used with standard PCR conditions for
30 cycles and the resulting fragment was cloned into pET101 using
the Champion pET Directional TOPO Expression Kit (Invitrogen,
Burlington, ON) and named ‘pET Bsu YesZ wt’. The mutation at
the acid/base position (E145A) was introduced using a four-primer
methodology. Outside primers were the same as above, the mutational
primers were Bsu_yes_E145Afw (GGC TGA TCG GAT GGC AGC
TAG ACA ATG CGT TCA A) and Bsu_yes_E145rv (ATT GTC
TAG CTG CCA TCC GAT CAG CC). Two fragments were ampliﬁed
in 15 cycles using the primer combinations Bsu_yes_fw/Bsu_yes_
E145Arv and Bsu_yes_rv/Bsu_yes_E145Afw and ’pET Bsu YesZ wt’
as template. In a second step the derived fragments were combined
and ampliﬁed using the primer combination Bsu_yes_fw/Bsu_yes_rv
and the resulting mutated fragment cloned into pET101 using the
above described technology and named ‘pET Bsu YesZ E145A’. The
insert of the derived plasmid was completely sequenced (NAPS unit,
UBC, Vancouver, BC) and found to be free of PCR errors. The con-
structs encoding the b-galactosidase gene and the E145A (acid/base)
mutant in pET101 vector were transformed into Escherichia coli
BL21 DE3 electrocompetent cells via electroporation. One litre of cul-
ture was grown in LB/Amp media at 37 C, inducing with 1 mM IPTG
after the cell OD reached 0.7 and was left to express protein overnight.
The cells were harvested and spun at 4 C for 30 min at 5000 · g to
produce the cell pellet, which was subsequently resuspended in Buﬀer
A (100 mM Tris pH 8.0, 500 mM NaCl, 20 mM imidazole) for puriﬁ-
cation.
2.3. Protein puriﬁcation
The resuspended cells were ruptured by passing them through a
French pressure cell (10000 psi) and cell debris was removed by centri-
fuging at 15000 · g for 30 min. The puriﬁcation of b-galactosidase
(YesZ) was accomplished by loading the supernatant onto a His-
TrapTM FF column (Amersham Biosciences) as the protein contains
a C-terminal His-tag. The column was equilibrated with Buﬀer A, then
eluted using a stepwise gradient of imidazole. YesZ b-galactosidase
was eluted from the column at an imidazole concentration of 75–
125 mM. The eluate was concentrated using an Amicon ultra-ﬁltration
unit (10000 MW cutoﬀ) and buﬀer-exchanged into 50 mM sodium
phosphate pH 7.0. SDS–PAGE showed the 77 kDa protein to be
>99% pure. Similar protocols were used for the expression and puriﬁ-
cation of the E145A acid/base mutant.
2.4. Enzyme kinetics
All experiments were carried out at 37 C in 50 mM phosphate buf-
fer, pH 7.0 containing 0.1% BSA. Kinetic parameters were determined
by measuring the initial linear increase in absorbance at 400 nm upon
addition of the enzyme (ﬁnal concentration 5.7 nM) to substrate p-
nitrophenyl b-D-galactopyranoside (PNPGal) at a range of concentra-
tions (typically 0.05–3 mM). Cuvettes had a path length of 1 cm and
were used in a Cary 4000 UV/visible spectrophotometer connected to
a circulating water bath. The rates were calculated using an extinction
coeﬃcient for p-nitrophenol at pH 7.0, 37 C of 9050 M1 cm1 via a
direct ﬁt of the data to the Michaelis–Menten equation using the pro-
gram GraFit 4.0 (Erithacus software).
Studies of inactivation kinetics were performed by pre-incubating
100 ll of the enzyme at 37 C with DNP2FGal at a range of concentra-
tions from 0.005 mM to 0.3 mM in a total volume of 140 ll. The con-
centrations of enzyme in these inactivation mixtures were: WT,
41.0 nM; E145A, 14.1 lM. Aliquots (20 ll) were withdrawn at regular
time intervals and added to 180 lL of pNPGal that had been pre-incu-
bated in 50 mM phosphate buﬀer, pH 7.0 at 37 C. The initial rates at
each time point were plotted as a function of time to obtain time-
dependent exponential decay curves from which kobs could be obtained
for each inactivator concentration using the ﬁrst-order rate equation:
rate = A0e
kt + oﬀset (k = ki,obs), in GraFit 4.0 [19]. Since the rates did
not decay to zero, the single exponential decay with oﬀset was used.
Values of the inactivation parameters Ki and ki were obtained from
the ﬁts of a plot of kobs versus inactivator concentration to the equa-
tion: kobs = ki · [I]/(KI+ [I]) [19].2.5. Labelling and proteolysis
A sample of the E145A (acid–base) mutant of YesZ (100 ll of
0.2 mg/mL in 50 mM sodium phosphate, pH 7.0) was incubated with
5 lL of DNP2FGal (3 mM in water) for 2 h at 37 C. Complete inac-
tivation was evidenced by assay of a 20 ll aliquot of the enzyme/inhib-
itor mixture with 3 mM PNPGal. The intact protein and control
sample (as above with 5 lL H2O instead of inhibitor) were subjected
to proteolysis by diluting the samples with 10 ll of a pepsin solution
(0.1 mg/ml in 50 mM phosphate buﬀer, pH 2.0) and 60 lL of
500 mM phosphate buﬀer, pH 2.0 and incubated for 3 h at room tem-
perature. The sample was then frozen until ready for analysis and was
used immediately upon thawing.
2.6. Electrospray ionization mass spectrometry (ESI-MS)
Mass spectra were recorded using an ABI MDS-SCIEX API
QSTAR Pulsar i mass spectrometer (Sciex, Thornhill, ON). Peptides
were separated by reverse phase C18 column on an Ultimate HPLC
system (LC Packings, Amsterdam, Netherlands) interfaced with the
mass spectrometer.
For LC/MS experiments, proteolytic digests of proteins were loaded
onto a C18 column (LC Packings, 75 lm i.d. · 150 mm PepMap) and
eluted with a gradient of 2–40% solvent B over the course of 60 min at
a ﬂow rate of 0.2 lL/min (Solvent A, 0.1% formic acid and 2% aceto-
nitrile in water; solvent B, 0.1% formic acid and 85% acetonitrile in
water). The TOF data were acquired over a mass-to-charge ratio range
of 300–2000 amu, with a step size of 0.1 amu and with a scan time of
1 s. The ion source potential was set at 2.2 kV; the oriﬁce energy was
50 V. Intact proteins were run on a C4 column (PLRP-S 0.75 lm
i.d. · 50 mm, 8 lm, 4000A, Michrom BioResources, Inc., Auburn,
CA, USA) on an Ultimate HPLC system and interfaced to the mass
spectrometer as above. They were eluted with a gradient of 15% sol-
vent B to 80% solvent B over 15 min, 80% solvent B for 5 min and ﬁ-
nally 15% solvent B for 15 min. To determine the amino acid sequence,
the mass spectrometer was operated in an IDA (Information Depen-
dent Acquisition) MS/MS mode.3. Results and discussion
3.1. Enzyme kinetics
Kinetic parameters for the hydrolysis of pNPGal by wild
type YesZ of kcat = 81 ± 4 s
1, Km = 3.0 ± 0.2 mM, kcat/Km =
27 ± 2 mM1 s1 were determined. Likewise those for the
E145A (acid/base) variant were: kcat = 0.13 ± 0.01 s
1, Km =
0.047 ± 0.003 mM, kcat/Km = 2.8 ± 0.08 mM
1 s1. The low
Km observed for the E145A mutant is most likely not a conse-
quence of tighter reversible binding of the inhibitor, but rather
a consequence of the accumulation of a covalent glycosyl-en-
zyme intermediate on the mutant. Such an accumulation oc-
curs because the hydrolysis of the covalent glycosyl-enzyme
intermediate is slowed substantially by removal of the base cat-
alyst while formation of the intermediate remains fast for sub-
strates with a good leaving group that does not need acid
catalytic assistance for departure. Since the expression for
Km can be written as below, where
P
[ES] represents the sum
of all enzyme substrate complexes, when an intermediate accu-
mulates the Km value will necessarily be lowered
Km ¼ ½E  ½SP½ES
Consequently the observation of a low Km represents support-
ive evidence for, though not yet full proof of, the role of E145
as the acid/base catalyst.
3.2. Time-dependent inactivation of YesZ by DNP2FGal
Time-dependent inactivation of both the wild type YesZ and
of the putative acid/base mutant (E145A) of YesZ was seen
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Fig. 1. Interestingly inactivation of the wild type enzyme was
incomplete at lower inactivator concentrations as seen in
Fig. 1A. Such behaviour has been seen and characterized pre-
viously [20] and arises when turnover of the intermediate via
hydrolysis or transglycosylation occurs at rates close to those
of its formation. Complete inactivation was seen, however,
for the acid/base mutant E145A, as expected. This change in
behaviour arises because removal of the acid catalyst does
not substantially aﬀect glycosylation rate constants when a
very good leaving group such as dinitrophenol, that does not
require protonic assistance for departure, is used [21]. However
the absence of base catalysis severely slows the hydrolysis of
the glycosyl-enzyme intermediate, thus complete inactivation
is observed. This is essentially the same phenomenon as that
which gives rise to low substrate Km values as described earlier.
Replots of the pseudo-ﬁrst-order rate constants for inactiva-Fig. 1. Time-dependent inactivation of WT and E145A enzymes using DNP
decay to a non-zero value when DNP2FGal was incubated with (A) WT
phosphate buﬀer at pH 7.0. Inactivator (DNP2FGal) concentrations are a
¤0.005 mM, e 0.01 mM, , 0.05 mM, m 0.075 mM, h 0.10 mM, 0.30 mM
single exponential decay with oﬀset using Graﬁt 4.0) versus inactivator conce
from which ki and KI were obtained. The reciprocal plots are shown as insetion at each inactivator concentration for both enzymes
yielded the following values of the inactivation parameters.
Wild type YesZ: ki = (5.0 ± 0.3) · 103 s1, Ki = 0.8 ±
0.3 mM, ki/Ki = (6.3 ± 0.4) · 103 s1 mM1 and E145A:
ki = (11.2 ± 0.7) · 103 s1, Ki = 0.21 ± 0.02 mM, ki/KI =
(53 ± 3) · 103 s1 M1.
3.3. Identiﬁcation of the catalytic nucleophile of YesZ
Since the inactivation of the acid/base mutant (E145A) by
DNP2FGal proceeded essentially to completion, this enzyme
form was selected for the peptide mapping studies. The stoichi-
ometry of inactivation was ﬁrst checked by measuring the
intact protein mass by electrospray ionization mass spectrom-
etry on a Q-TOF instrument. A mass, [M + H]+, of 77470 (±2)
Da was measured for the unlabelled mutant, reasonably con-
sistent with the predicted mass of 77440 Da, while two peaks
at 77470 (±2) Da and 77634 (±2) Da were observed for the2FGal. Time-dependent inactivation observed as a single exponential
and (B) E145A mutant. Assays were performed at 37 C in 50 mM
s follows: (a) ¤0.075 mM, n 0.10 mM, n 0.25 mM,  0.50 mM; (b)
. A plot of ki, obs, (obtained from ﬁtting the curves in (a) and (b) to a
ntration gave hyperbolic saturation plots for (C) WT and (D) E145A,
ts. The structure of DNP2FGal is illustrated in (E).
Fig. 2. Detection of the 2-deoxy-2-ﬂuorogalactosyl-labelled peptide by ESI-MS Mass spectra of (A) unlabelled enzyme digests eluted at 18 min and
(B) and (C) labelled enzyme digests eluted at 16 and 15 min, respectively. Arrows point to the parent fragment of 1025 present in control and labelled
digests and the labelled fragment at 1189 amu, which corresponds to the label mass diﬀerence of 164 amu.
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conﬁrms the incorporation of a single 2-deoxy-2-ﬂuorogalacto-
syl moiety of mass 165.
Samples of the inactivated E145A variant and non-inacti-
vated control were subjected to pepsin digestion at pH 2.0
and the resultant peptic digests were, individually, separated
on an HPLC attached to an ESI-MS detector. Comparison
of the elution proﬁles of the digests of the control and inacti-
vated E145A variants revealed essentially identical proﬁles ex-
cept for a single peptide (m/z 1189.5) that was present in the
labelled sample, but absent from the unlabelled enzyme
(Fig. 2). However, both proﬁles contain a peak at m/z 1025.4
that corresponds, within error, to the equivalent unlabelled
peptide (1189.5 minus the label of 165). This peptide, which
is presumably the labelled peptide of interest, was then se-
quenced by collision-induced fragmentation, as shown in
Fig. 3.
A major fragment peak observed is that of a singly charged
ion of m/z 1025, which corresponds to the loss of the 2-ﬂuo-
rogalactosyl moiety as a neutral species, thereby conﬁrming
that this is indeed the peptide of interest. Further analysis
of the fragmentation pattern of the parent peptide fragment
of mass 1025 Da reveals the sequence ETSPSYAASL from
the b-ion and y-ion peaks as shown in Fig. 3. The spectrum
also reveals four labelled peptide fragments of m/z 829, 900,
971, and 1058, which are consistent with peptides ETSPSY,
ETSPSYA, ETSPSYAA, and ETSPSYAAS, each bearing
the 2FGal moiety. Comparison of this sequence with that ofYesZ derived from the genome sequence shows that this pep-
tide corresponds to the region of sequence starting with Glu-
tamic acid 295. Since this sequence contains only one
carboxylic acid and since carboxylic acids act as the enzymatic
nucleophile in all known retaining glycosidases with the
exception of sialidases, which use a tyrosine [22] and Family
4 glycosidases, which use an entirely diﬀerent mechanism
[23] these results suggest that, as predicted, the nucleophile
in this enzyme is Glutamate 295. Assignment of Glu295 as
the catalytic nucleophile is consistent with the complete con-
servation of this residue in the sequences of Family 42 galac-
tosidases, as shown in Fig. 4A.
In summary, the results described herein provide unequivo-
cal evidence for the role of Glu295 in the b-galactosidase YesZ
from Bacillus subtilis as the catalytic nucleophile, thus by anal-
ogy identifying the homologous residue in all members of
Family GH42. The tentative assignment of Glu145 as the
acid/base catalyst, as suggested by the conservation of this res-
idue in the sequences of Family 42 galactosidases (Fig. 4B),
and by the crystallographic results, is strengthened through ki-
netic analysis of mutants modiﬁed at that position, since the
accumulation of a glycosyl-enzyme intermediate upon reaction
with activated substrates is a hallmark of a mutant modiﬁed at
that position. This completes the experimental assignment of
catalytic nucleophiles in known retaining b-galactosidase fam-
ilies. Further it reduces the number of current Clan GH-A
members for which unequivocal experimental assignment has
not yet been achieved to ﬁve.
Fig. 3. ESI-MS/MS analysis of the 2-deoxy-2-ﬂuorogalactosyl-labelled peptide (A) MS/MS daughter-ion spectrum of the labelled peptide. Observed
b-ion and y-ion fragments are shown in the spectra. (B) Fragmentation pattern of the peptide and assignment of the singly charged y- and b-ions
from the fragment ion spectra. Masses shown in the pattern are those observed in the spectrum. Glutamate is shown as the predicted labeled residue.
Fig. 4. Partial multiple sequence alignment of representative family 42 enzymes. (A) The region around the nucleophile residue: the nucleophile is in
bold. (B) The region around the putative acid/base catalyst: the candidate residue is shown in bold. Swiss Prot. identiﬁers are indicated in parentheses
below. The sequences shown are Thermus sp. A4 b-galactosidase (O69315), Bacillus subtilis b-galactosidase (O07012), Clostridium perfringens b-
galactosidase (Q59312), Bacillus circulans b-galactosidase (Q45092), Geobacillus stearothermophilus b-galactosidase (P19668), Thermotoga maritima
b-galactosidase (Q56306), Thermotoga neapolitana b-galactosidase (O85248), Thermus sp. T2 b-galactosidase (O54315), Haloferax lucentense b-
galactosidase (P94804).
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